{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:50:54Z","timestamp":1791337854895,"version":"4.3.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:00:00Z","timestamp":1612656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:00:00Z","timestamp":1612656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00213-021-05779-x","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T02:50:44Z","timestamp":1612839044000},"page":"1495-1511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation"],"prefix":"10.1007","volume":"238","author":[{"given":"Ramakrishna","family":"Nirogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Benade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saivishal","family":"Daripelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Kamuju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopinadh","family":"Bhyrapuneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nageswara Rao","family":"Muddana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat Reddy","family":"Mekala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Petlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Jayarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Badange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Jasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,7]]},"reference":[{"key":"5779_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0306-4522(87)90279-X","volume":"23","author":"JM Arrang","year":"1987","unstructured":"Arrang JM, Garbarg M, Schwartz JC (1987) Auto-inhibition of histamine synthesis mediated by presynaptic H3 receptors. Neuroscience 23:149\u2013157","journal-title":"Neuroscience"},{"key":"5779_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2210-8-9","volume":"8","author":"JG Baker","year":"2008","unstructured":"Baker JG (2008) Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells. BMC Pharmacol 8:9","journal-title":"BMC Pharmacol"},{"key":"5779_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0014-2999(93)90632-R","volume":"250","author":"J Barnes","year":"1993","unstructured":"Barnes J, Brown J, Clarke N, Clapham J, Evans D, O\u2019Shaughnessy C (1993) Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist. Eur J Pharmacol 250:147\u2013152","journal-title":"Eur J Pharmacol"},{"key":"5779_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","volume":"15","author":"CLA Bassetti","year":"2019","unstructured":"Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, Khatami R, Koning F, Kornum BR, Lammers GJ, Liblau RS, Luppi PH, Mayer G, Pollm\u00e4cher T, Sakurai T, Sallusto F, Scammell TE, Tafti M, Dauvilliers Y (2019) Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 15:519\u2013539","journal-title":"Nat Rev Neurol"},{"key":"5779_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pneurobio.2015.12.002","volume":"152","author":"SW Black","year":"2017","unstructured":"Black SW, Yamanaka A, Kilduff TS (2017) Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 152:89\u2013113","journal-title":"Prog Neurobiol"},{"key":"5779_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","volume":"63","author":"RE Brown","year":"2001","unstructured":"Brown RE, Stevens DR, Haas HL (2001) The physiology of brain histamine. Progr Neurobiol 63:637\u2013672","journal-title":"Progr Neurobiol"},{"key":"5779_CR7","doi-asserted-by":"publisher","first-page":"12305","DOI":"10.1523\/JNEUROSCI.2630-12.2012","volume":"32","author":"CR Burgess","year":"2012","unstructured":"Burgess CR, Scammell TE (2012) Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 32:12305\u201312311","journal-title":"J Neurosci"},{"key":"5779_CR8","unstructured":"Campbell P, https:\/\/www.mdmag.com\/medical-news\/fda-approves-oncedaily-sunosi-for-narcolepsy-osa-patients. Accessed on 29-Oct-2019."},{"key":"5779_CR9","doi-asserted-by":"crossref","unstructured":"C\u00e9lanire S,Wijtmans M, Christophe B, Collart P, de Esch I, Dassesse D et al. (2009) Discovery of a new class of non-imidazole oxazoline-based 750 histamine H(3) receptor (H(3)R) inverse agonists. Chem Med Chem 4(7):1063\u20131068","DOI":"10.1002\/cmdc.200900055"},{"key":"5779_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","volume":"47","author":"G Di Chiara","year":"2004","unstructured":"Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C et al (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47:227\u2013241","journal-title":"Neuropharmacology"},{"key":"5779_CR11","first-page":"378.11","volume":"27","author":"T Esbenshade","year":"2001","unstructured":"Esbenshade T, Krueger K, Denny L, Miller T, Kang C, Witte D, Yao B, Black L, Bennani Y, Fox G et al (2001) Complex pharmacological effects of GT-2331. Soc Neurosci Abstr 27:378.11","journal-title":"Soc Neurosci Abstr"},{"key":"5779_CR12","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"K Franklin","year":"2007","unstructured":"Franklin K, Paxinos G (2007) The Mouse Brain in Stereotaxic Coordinates. Academic Press, New York"},{"issue":"19","key":"5779_CR13","doi-asserted-by":"publisher","first-page":"11086","DOI":"10.1073\/pnas.1932276100","volume":"100","author":"F Gbahou","year":"2003","unstructured":"Gbahou F, Rouleau A, Morisset S, Parmentier R, Crochet S, Lin JS, Ligneau X, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM (2003) Protean agonism at histamine H3 receptors in vitro and in vivo. PNAS 100(19):11086\u201311091","journal-title":"PNAS"},{"key":"5779_CR14","unstructured":"George J. https:\/\/www.medpagetoday.com\/neurology\/sleepdisorders\/81626. Accessed on 29-Oct-2019."},{"issue":"10","key":"5779_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.sleep.2013.04.010","volume":"14","author":"WJ Herring","year":"2013","unstructured":"Herring WJ, Liu K, Hutzelmann J, Snavely D, Snyder E, Ceesay P, Lines C, Michelson D, Roth T (2013) Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomised adaptive crossover study. Sleep Med 14(10):955\u2013963","journal-title":"Sleep Med"},{"key":"5779_CR16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1124\/jpet.102.046581","volume":"305","author":"CL Hofstra","year":"2003","unstructured":"Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP (2003) Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 305:1212\u20131221","journal-title":"J Pharmacol Exp Ther"},{"key":"5779_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0014-2999(01)01518-7","volume":"433","author":"L Ireland-Denny","year":"2001","unstructured":"Ireland-Denny L, Parihar A, Miller T, Kang C, Krueger K, Esbenshade T et al (2001) Species-related pharmacological heterogeneity of histamine H3 receptors. Eur J Pharmacol 433:141\u2013150","journal-title":"Eur J Pharmacol"},{"key":"5779_CR18","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1073\/pnas.1700499114","volume":"114","author":"Y Irukayama-Tomobe","year":"2017","unstructured":"Irukayama-Tomobe Y, Ogawa Y, Tominaga H, Ishikawa Y, Hosokawa N, Ambai S, Kawabe Y, Uchida S, Nakajima R, Saitoh T, Kanda T, Vogt K, Sakurai T, Nagase H, Yanagisawa M (2017) Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models. Proc Natl Acad Sci U S A. 114:5731\u20135736","journal-title":"Proc Natl Acad Sci U S A."},{"key":"5779_CR19","first-page":"e97","volume":"8","author":"EI Koziorynska","year":"2011","unstructured":"Koziorynska EI, Rodriguez AJ (2011) Narcolepsy: clinical approach to etiology, diagnosis, and treatment. Rev Neurol Dis. 8:e97\u2013e106","journal-title":"Rev Neurol Dis."},{"issue":"12","key":"5779_CR20","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1517\/13543784.2011.625010","volume":"20","author":"S Kuhne","year":"2011","unstructured":"Kuhne S, Wijtmans M, Lim HD, Leurs R, de Esch IJ (2011) Several down, a few to go: histamine H3 receptor ligands making the final push towards the market? Expert Opin Investig Drugs 20(12):1629\u20131648","journal-title":"Expert Opin Investig Drugs"},{"key":"5779_CR21","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1111\/j.1476-5381.1995.tb15071.x","volume":"116","author":"R Leurs","year":"1995","unstructured":"Leurs R, Tulp MT, Menge WM, Adolfs MJ, Zuiderveld OP, Timmerman H (1995) Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Br J Pharmacol 116:2315\u20132321","journal-title":"Br J Pharmacol"},{"key":"5779_CR22","first-page":"658","volume":"287","author":"X Ligneau","year":"1998","unstructured":"Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir J, Ganellin C, Stark H, Elz S, Schunack W, Schwartz J (1998) Neurochemical and behavioral effect of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther 287:658\u2013666","journal-title":"J Pharmacol Exp Ther"},{"key":"5779_CR23","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/sj.bjp.0703712","volume":"131","author":"X Ligneau","year":"2000","unstructured":"Ligneau X, Morisset S, Tardivel-Lacombe J, Gbahou F, Ganellin CR, Stark H, Schunack W, Schwartz JC, Arrang JM (2000) Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain. Br J Pharmacol 131:1247\u20131250","journal-title":"Br J Pharmacol"},{"key":"5779_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0006-8993(90)91508-E","volume":"523","author":"JS Lin","year":"1990","unstructured":"Lin JS, Sakai K, Vanni Mercier G, Arrang JM, Garbarg M, Schwartz JC et al (1990) Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. Brain Res 523:325\u2013330","journal-title":"Brain Res"},{"key":"5779_CR25","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1523\/JNEUROSCI.16-04-01523.1996","volume":"16","author":"JS Lin","year":"1996","unstructured":"Lin JS, Hou Y, Sakai K, Jouvet M (1996) Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 16:1523\u20131537","journal-title":"J Neurosci"},{"key":"5779_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","volume":"30","author":"JS Lin","year":"2008","unstructured":"Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, Kocher L, Yanagisawa M, Lehert P, Ligneau X, Perrin D, Robert P, Roux M, Lecomte JM, Schwartz JC (2008) An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin knockout mice and patients. Neurobiol Dis. 30:74\u201383","journal-title":"Neurobiol Dis."},{"key":"5779_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1124\/mol.59.3.420","volume":"59","author":"CL Liu","year":"2001","unstructured":"Liu CL, Ma XJ, Jiang XX, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg TW (2001) Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59:420\u2013426","journal-title":"Mol Pharmacol"},{"key":"5779_CR28","first-page":"771","volume":"293","author":"TW Lovenberg","year":"2000","unstructured":"Lovenberg TW, Pyati J, Chang H, Wilson SJ, Erlander MG (2000) Cloning of rat histamine H3 receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Ther 293:771\u2013778","journal-title":"J Pharmacol Exp Ther"},{"key":"5779_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41583-018-0097-x","volume":"20","author":"CE Mahoney","year":"2019","unstructured":"Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE (2019) The neurobiological basis of narcolepsy. Nat Rev Neurosci. 20:83\u201393","journal-title":"Nat Rev Neurosci."},{"key":"5779_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF01250237","volume":"72","author":"JM Monti","year":"1988","unstructured":"Monti JM, D\u2019angelo L, Jantos H, Prazos S (1988) Effects of a-fluoromethylhistidine on sleep and wakefulness in the rat. J Neural Transm 72:141\u2013145","journal-title":"J Neural Transm"},{"key":"5779_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0014-2999(91)90911-9","volume":"205","author":"JM Monti","year":"1991","unstructured":"Monti JM, Jantos H, Boussard M, Altier H, Orellana C, Olivera S (1991) Effects of selective activation or blockade of the histamine H3 receptor on sleep and wakefulness. Eur J Pharmacol 205:283\u2013287","journal-title":"Eur J Pharmacol"},{"key":"5779_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0893-133X(95)00151-3","volume":"15","author":"JM Monti","year":"1996","unstructured":"Monti JM, Jantos H, Ponzoni A, Monti D (1996) Sleep and waking during acute histamine H3 agonist BP 2.94 or H3 antagonist carboperamide (MR 16155) administration in rats. Neuropsychopharmacology 15:31\u201335","journal-title":"Neuropsychopharmacology"},{"key":"5779_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35048583","volume":"408","author":"S Morisset","year":"2000","unstructured":"Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Arrang JM (2000) High constitutive activity of native H3receptors regulates histamine neurons in the brain. Nature 408:860\u2013864","journal-title":"Nature"},{"key":"5779_CR34","unstructured":"National Institute of Health. Narcolepsy (2017) Publication No. 17-1637. May 2017. https:\/\/catalog.ninds.nih.gov\/pubstatic\/17-1637\/17-1637.pdf. Accessed March 28, 2019"},{"issue":"3","key":"5779_CR35","first-page":"427","volume":"24","author":"JF Navarro","year":"2012","unstructured":"Navarro JF, Beltr\u00e1n D, Cavas M (2012) Effects of (+) SKF 10,047, a sigma-1 receptor agonist, on anxiety, tested in two laboratory models in mice. Psicothema 24(3):427\u2013430","journal-title":"Psicothema"},{"key":"5779_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13318-012-0081-1","volume":"37","author":"R Nirogi","year":"2012","unstructured":"Nirogi R, Bhyrapuneni G, Kandikere V, Benade V, Muddana N, Saralaya R, Irappanavar S, Ponnamaneni R, Mukkanti K (2012) Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats. Eur J Drug Metab Pharmacokinet 37:155\u2013161","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"3","key":"5779_CR37","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1021\/acs.jmedchem.8b01280","volume":"62","author":"R Nirogi","year":"2019","unstructured":"Nirogi R, Shinde A, Mohammed AR, Badange RK, Reballi V, Bandyala TR, Saraf SK, Bojja K, Manchineella S, Achanta PK, Kandukuri KK, Subramanian R, Benade V, Palacharla RC, Jayarajan P, Pandey S, Jasti V (2019) Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting Activity. J Med Chem 62(3):1203\u20131217","journal-title":"J Med Chem"},{"key":"5779_CR38","doi-asserted-by":"publisher","first-page":"7695","DOI":"10.1523\/JNEUROSCI.22-17-07695.2002","volume":"22","author":"R Parmentier","year":"2002","unstructured":"Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS (2002) Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep\u2013wake control. J Neurosci 22:7695\u20137711","journal-title":"J Neurosci"},{"key":"5779_CR39","volume-title":"Rat brain in stereotaxic coordinates","author":"G Paxinos","year":"2007","unstructured":"Paxinos G, Watson C (2007) Rat brain in stereotaxic coordinates. Academic Press, New York"},{"key":"5779_CR40","doi-asserted-by":"publisher","first-page":"7272","DOI":"10.1523\/JNEUROSCI.22-16-07272.2002","volume":"22","author":"C Pillot","year":"2002","unstructured":"Pillot C, Ortiz J, H\u00e9ron A, Ridray S, Schwartz JC, Arrang JM (2002) Ciproxifan, a histamine H3-receptor antagonist\/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat. J Neurosci 22:7272\u20137280","journal-title":"J Neurosci"},{"key":"5779_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neuropharm.2018.10.028","volume":"144","author":"DM Riddy","year":"2019","unstructured":"Riddy DM, Cook AE, Shackleford DM, Pierce TL, Mocaer E, Mannoury la Cour C, Sors A, Charman WN, Summers RJ, Sexton PM, Christopoulos A, Langmead CJ (2019) Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists. Neuropharmacology 144:244\u2013255","journal-title":"Neuropharmacology"},{"key":"5779_CR42","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.2147\/DDDT.S101145","volume":"12","author":"A Romigi","year":"2018","unstructured":"Romigi A, Vitrani G, Giudice LT, Centonze D, Franco V (2018) Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy. Drug Des Devel Ther 12:2665\u20132675","journal-title":"Drug Des Devel Ther"},{"key":"5779_CR43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/sj.bjp.0704490","volume":"135","author":"A Rouleau","year":"2002","unstructured":"Rouleau A, Ligneau X, Tardivel-Lacombe J, Morriset S, Gbahou F, Schwartz JC et al (2002) Histamine H3-receptor mediated [35S] GTP\u03b3S binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors. Br J Pharmacol 135:383\u2013392","journal-title":"Br J Pharmacol"},{"key":"5779_CR44","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMra1500587","volume":"373","author":"TE Scammell","year":"2015","unstructured":"Scammell TE (2015) Narcolepsy. N Engl J Med 373:2654\u20132662","journal-title":"N Engl J Med"},{"key":"5779_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5665\/sleep\/32.1.111","volume":"32","author":"TE Scammell","year":"2009","unstructured":"Scammell TE, Willie JT, Guilleminault C, Siegel JM (2009) A consensus definition of cataplexy in mouse models of narcolepsy. Sleep 32:111\u2013116","journal-title":"Sleep"},{"key":"5779_CR46","doi-asserted-by":"crossref","unstructured":"Scammell TE, Jackson AC, Franks NP, Wisden W, Dauvilliers Y. Histamine: neural circuits and new medications. Sleep 2019; 42: zsy183","DOI":"10.1093\/sleep\/zsy183"},{"key":"5779_CR47","first-page":"189","volume":"2","author":"O Schild","year":"1947","unstructured":"Schild O (1947) pA2, A new scale for the measurement of drug antagonism. Br J Pharmacol 2:189\u2013206","journal-title":"Br J Pharmacol"},{"key":"5779_CR48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","volume":"163","author":"JC Schwartz","year":"2011","unstructured":"Schwartz JC (2011) The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol 163:713\u2013721","journal-title":"Br J Pharmacol"},{"key":"5779_CR49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1073\/pnas.012506099","volume":"99","author":"RB Silver","year":"2002","unstructured":"Silver RB, Poonwasi KS, Seyedi N, Wilson SJ, Lovenberg TW, Levi R (2002) Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings. Proc Natl Acad Sci U.S.A 99:501\u2013506","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"5779_CR50","first-page":"507","volume":"21","author":"H Stark","year":"1996","unstructured":"Stark H, Schlicker E, Schunack W (1996) Developments of histamine H3-receptor antagonists. Drugs Future 21:507\u2013520","journal-title":"Drugs Future"},{"key":"5779_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.smrv.2018.09.006","volume":"43","author":"ST Szabo","year":"2019","unstructured":"Szabo ST, Thorpy MJ, Mayer G, Peever JH, Kilduff TS (2019) Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Sleep Med Rev. 43:23\u201336","journal-title":"Sleep Med Rev."},{"key":"5779_CR52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0014-2999(98)00396-3","volume":"351","author":"CE Tedford","year":"1998","unstructured":"Tedford CE, Hoffmann M, Seyedi N, Maruyama R, Levi R, Yates SL et al (1998) High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models. Eur J Pharmacol 351:307\u2013311","journal-title":"Eur J Pharmacol"},{"key":"5779_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/mol.62.2.389","volume":"62","author":"H Toyota","year":"2002","unstructured":"Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW (2002) Behavioral characterization of mice lacking histamine H3 receptors. Mol Pharmacol 62:389\u2013397","journal-title":"Mol Pharmacol"},{"key":"5779_CR54","unstructured":"Wakix prescribing information. https:\/\/wakixhcp.com\/assets\/pdf\/WAKIX%20(pitolisant)%20tablets%20PI%20Oct%202020.pdf. Accessed on 16-Oct-2020."},{"key":"5779_CR55","first-page":"908","volume":"299","author":"K Wieland","year":"2001","unstructured":"Wieland K, Bongers G, Yamamoto Y, Hashimoto T, Yamatodani A, Menge WMBP et al (2001) Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists. J Pharmacol ExpTher 299:908\u2013914","journal-title":"J Pharmacol ExpTher"},{"key":"5779_CR56","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0028-3908(03)00056-X","volume":"44","author":"BB Yao","year":"2003","unstructured":"Yao BB, Hutchins CW, Carr TL, Cassar SC, Masters JN, Bennani YL, Esbenshade TA, Hancock AA (2003) Molecular modeling and pharmacological analysis of species related histamine H3 receptor heterogeneity. Neuropharmacology 44:773\u2013786","journal-title":"Neuropharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05779-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T03:05:08Z","timestamp":1674961508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,7]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5779"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05779-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,7]]},"assertion":[{"value":"19 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}